Option/Bio, Год журнала: 2025, Номер 36(701-702), С. 12 - 12
Опубликована: Март 1, 2025
Option/Bio, Год журнала: 2025, Номер 36(701-702), С. 12 - 12
Опубликована: Март 1, 2025
Pathogens, Год журнала: 2025, Номер 14(2), С. 196 - 196
Опубликована: Фев. 15, 2025
The Bacillus Calmette-Guérin (BCG) vaccine, best known for its role in preventing tuberculosis, has recently garnered attention broader immunomodulatory effects. By inducing trained immunity, BCG reprograms innate immune cells, enhancing their responses to various pathogens. This process, driven by epigenetic and metabolic reprogramming, suggests that may have therapeutic potential far beyond tuberculosis. Emerging evidence points benefits conditions such as autoimmune diseases, cancer, viral infections. Furthermore, modulating activity, been proposed reduce chronic inflammation promote tolerance. review delves into the multifaceted of BCG, highlighting a versatile tool managing wide range diseases.
Язык: Английский
Процитировано
1Option/Bio, Год журнала: 2025, Номер 36(701-702), С. 12 - 12
Опубликована: Март 1, 2025
Процитировано
0